- Research article
- Open Access
- Open Peer Review
Characteristics of myogenic response and ankle torque recovery after lengthening contraction-induced rat gastrocnemius injury
© Song et al.; licensee BioMed Central Ltd. 2012
- Received: 21 May 2012
- Accepted: 22 October 2012
- Published: 30 October 2012
Although muscle dysfunction caused by unfamiliar lengthening contraction is one of most important issues in sports medicine, there is little known about the molecular events on regeneration process. The purpose of this study was to investigate the temporal and spatial expression patterns of myogenin, myoD, pax7, and myostatin after acute lengthening contraction (LC)-induced injury in the rat hindlimb.
We employed our originally developed device with LC in rat gastrocnemius muscle (n = 24). Male Wistar rats were anesthetized with isoflurane (aspiration rate, 450 ml/min, concentration, 2.0%). The triceps surae muscle of the right hindlimb was then electrically stimulated with forced isokinetic dorsi-flexion (180°/sec and from 0 to 45°). Tissue contents of myoD, myogenin, pax7, myostatin were measured by western blotting and localizations of myoD and pax7 was measured by immunohistochemistry. After measuring isometric tetanic torque, a single bout of LC was performed in vivo.
The torque was significantly decreased on days 2 and 5 as compared to the pre-treatment value, and recovered by day 7. The content of myoD and pax7 showed significant increases on day 2. Myogenin showed an increase from day 2 to 5. Myostatin on days 5 and 7 were significantly increased. Immunohistochemical analysis showed that myoD-positive/pax7-positive cells increased on day 2, suggesting that activated satellite cells play a role in the destruction and the early recovery phases.
We, thus, conclude that myogenic events associate with torque recovery after LC-induced injury.
- Muscle injury
- Eccentric contraction
- Myogenic factor
Excessive lengthening contraction (LC) causes different types of damage to skeletal muscles including temporary muscle dysfunction, delayed onset muscle soreness (DOMS), and most importantly, muscle strain injury[1–4]. In particular, LC is reported to play a critical role in inducing muscle strain injury[3, 4]. Although there have been many clinical and laboratory studies evaluating biomechanical mechanisms of muscle injury[3, 5–8], the relationships between molecular events resulting from LC and functional recovery have not been fully understood.
In general, the healing process of muscle injury consists of 3 phases: the destruction phase, the repair phase, and the remodeling phase. During these 3 phases, activation of the quiescent satellite cells (SCs) plays a key role[10, 11]. Quiescent SCs expressing pax7 locate between the sarcolemma and the basal lamina in adult muscles[12, 13]. When activated by the damage, SCs upregulate one of the myogenic regulatory factors (MRFs), myoD, and become activated SCs. Activated SCs eventually become myoblasts, characterized by upregulated myogenin and downregulated pax7[15–17]. These activated myogenic cells contribute to hyperplasia or hypertrophy of the injured muscles.
In the remodeling phase, myogenic cells, along with the reformation of precise connective tissues, assume a crucial role. The reorganization and construction of unstructured connective tissue can occur, leading to scar tissue formation and subsequent incomplete skeletal muscle regeneration. Transforming growth factor-β1 (TGF-β1) is the primary factor contributing to fibrosis in various tissues, including skeletal muscles[19, 20]. TGF-β and its superfamily, including myostatin[21, 22], inhibit myogenic proliferation and differentiation via smad-mediated signal transduction. Thus, the TGF-β superfamily plays a key role in the maturation of myogenic cells as well as precise connective tissue formation.
In myotoxic and contusion injury models, the recovery processes of muscle injuries have been examined. Beitzel et al. showed that bupivacaine treated rat extensor digitorum longus (EDL) muscles had decreased EDL specific tension concomitant with decreased and regenerated muscle fiber cross-sectional area in hematoxylin-eosin (H & E) staining. Criso et al. and Iwata et al. demonstrated that contusion injury in the gastrocnemius resulted in significantly lower muscle strength. Crisco et al. showed that the tetanic tension of gastrocnemius returned to normal levels and, at the same time, there was no histological abnormality in H & E staining on 24 days after injury[25, 26]. Iwata et al. also showed that locomotion and the isometric plantarflexion force returned to the normal levels 21 days after contusion injury in rat gastrocnemii, but they found that the muscle fiber size did not return to the normal value in 21 days[25, 26]. There are still controversies between functional recovery and pathological findings in muscle injury. Especially, the relationships between myogenic proteins expressions and muscular functional recovery have not been fully examined. Further, such examinations have not been addressed to temporary muscle dysfunction caused by lengthening contraction, which frequently occur in sports situation.
With regard to strain injuries, a single LC or a passive stretch on an exposed muscle was used to elucidate the mechanisms of muscle strain injuries[3, 6, 7]. Since the exposed-muscle model includes highly invasive treatments (i.e. deep incision), it is hard to follow long term the physiological recovery process. In order to overcome these demerits, Best et al. and Song et al. showed that a minimally invasive method (without an incision) successfully induced muscle dysfunction and apparent pathologic damage in the tibia anterior or the gastrocnemius. Since their models avoided invasive treatment as much as possible, long-time the recovery processes can be examined, such as those in toxic and contusion muscle injury models.
This study investigated the relationship between the expression of myogenic proteins (myogenin, myoD, and pax7) and functional changes in the skeletal muscle after LC-induced injury. We hypothesized that the expressions of these proteins correlate with muscular torque recovery. To test our hypothesis, we employed the minimally invasive model of muscle injury reported by Song et al.. Furthermore, we also examined myostatin expression in order to evaluate the processes of myogenic and connective tissue formation during the remodeling phase.
24 Wistar rats (age, 12 weeks; body mass, 260–280 g) were used in this study (CLEA Japan, Tokyo, Japan). Animals were housed in individually ventilated cage (IVC) systems (Tecniplast, Italy) maintained at 22–24°C with a 12-h light/dark cycle. Water and food were given ad libitum during the experiments. All procedures were approved by the Ethical Committee of the Nippon Sports Science University on the Use of Animal Subjects in Research (ID: 008-A01).
Measurement of isometric tetanic torque
Isometric tetanic torque was measured as previously reported[8, 20, 27]. Maximal isometric plantar flexion torque was measured with a dynamometer at the ankle joint angle of 0° (defined as the angle at which the sole of the foot and the tibial bone are orthogonally positioned). Before the measurement, the right hindlimb was shaved for electrical stimulation. The rats were anesthetized and placed prostrate on a platform with their knee extended. The triceps surae muscle was stimulated supramaximally (pulse duration, 0.4 ms; frequency, 100 Hz; intensity, ~35 V) with self-adhesive surface electrodes connected to an electric stimulator and an isolator (SS-104 J; Nihon Koden, Japan). Measurements were made before the LC, and on days 2, 5, and 7 after the LC.
Experimental method for muscle contraction-induced injury
To observe the regenerating and the recovery process, a single lengthening contraction-induced injury was induced in vivo to the rat gastrocnemius as described previously. The right gastrocnemius was used for experimental intervention. The right hindlimb of all the animals were shaved, and each rat was then anesthetized with isoflurane (aspiration rate, 450 mL/min; concentration, 2.0%). At first, in the prone animal, the hindlimb was positioned by extending the knee and dorsiflexing the foot to 0°. The ankle angle of 0° was defined when the foot was aligned straight with the tibia. The limb and the body were secured with elastic bands to a steel support platform. The medial gastrocnemius was stimulated supramaximally by employing percutaneous electrical stimulation with self-adhesive surface electrodes connected to an electric stimulator and an isolator (SS-104 J; Nihon Koden, Japan). After achieving a fused tetanic activation, the foot was dorsiflexed from 0 to 45° at a velocity of 180°/sec, and then returned to the starting position. The stretching movement during the activation induced a single injurious LC to the medial gastrocnemius muscle. The animals were sacrificed prior to, and on days 2, 5, and 7 after the muscle injury (n = 6 at each time point) using isoflurane inhalation, and weighed their hindlimb triceps muscles (medial gastrocnemius, lateral gastrocnemius, plantaris, and soleus) were dissected and weighed.
For pathological evaluation, we excised a 2-mm thickness specimen in a transverse plane from gastrocnemius muscle bellies. The obtained specimen was embedded into OCT (Optimal Cutting Temperature) compound and immediately frozen in liquid N2. Other portions of medial gastrocnemius muscle (proximal and distal portions) were immediately frozen in liquid N2 for Western blot analysis. Specimens were stored at −80°C until analysis.
Western blot analysis
Rapidly frozen medial gastrocnemius muscles were macerated under liquid N2, and homogenized in RIPA buffer (50 mM Tris-Cl (pH 7.4), 150 mM NaCl, 5 mM ethylenediaminetetraacetic acid (EDTA), 0.5% sodium dodecyl sulfate (SDS), 1% deoxycholate, 0.1% Triton X-100, 1% Nonidet P-40 (NP-40), 0.05% mercaptoethanol, 10 mg/mL phenylmethylsulfonyl fluoride (PMSF), 0.5 mg/mL leupeptin, 0.2 mg/mL aprotinin, and 1 mM Na3VO4). Protein concentrations were determined using Bio-Rad Protein Assay (Protein Assay II; Bio-Rad, Richmond, VA). The equivalent of 30 μg of total protein extract from each sample was mixed with sample buffer, boiled, and loaded onto a SDS-polyacrylamide gel (10%), and electrophoresed at 20 mA. The samples were electrophoretically separated at 180 mA for 90 min and then transferred onto polyvinylidene difluoride (PVDF) membranes (ATTO, Japan). The membranes were blocked for 1 h with phosphate-buffered saline (PBS) containing 5% skimmed milk followed by an overnight incubation at 4°C with a 1:1000 dilution of the following primary antibodies. All primary antibodies were incubated overnight at 4°C (dilution, 1:1000): monoclonal anti-myoD (DAKO, Capinteria, CA), monoclonal anti-myogenin (DAKO, Capinteria, CA), polyclonal anti-myostatin (Millipore, Billerica, MA), polyclonal anti-pax7 (Abcam, Cambridge, MA), and alpha-tubulin loading control (Abcam, Cambridge, MA). Membranes were washed 3 times for 10 min each at room temperature, followed by incubation with secondary horseradish peroxidase-conjugated goat anti-rat immunoglobulin G (IgG) or anti-rabbit IgG at a dilution of 1:10,000. The proteins were detected using chemiluminescence reagents (SuperSignal West Dura; Pierce Protein Research Products, Rockford, IL) with a chemiluminescence detector (AE6961; ATTO, Japan), and quantified using a personal computer with image analysis software (CS Analyzer; ATTO, Japan). The band densities were expressed relative to those obtained for the loading control.
Frozen medial gastrocnemius blocks were transversely sectioned with a Cryostat (CM 1500, Leica, Germany) at −20°C. Sections (10 μm) from the mid-belly portion of the medial gastrocnemius muscle were air dried for 15 min, then fixed using 4% paraformaldehyde in a 0.1 M phosphate buffer (pH 7.4) for 15 min. The sections were then washed in 0.1 M PBS and incubated with 0.1 M PBS containing 10% normal serum and 0.3% Triton X-100 for 1 h at RT to block nonspecific binding. For triple-immunofluorescence staining, sections were incubated simultaneously with primary antibodies diluted with 0.1 M PBS containing 5% normal serum, and 0.3% Triton X-100 for 20 h at 4°C. The primary antibodies used were polyclonal anti-myoD (1:200; DAKO, CA), polyclonal anti-myogenin (1:200; DAKO, CA), polyclonal anti-pax7 (Abcam, Cambridge, MA), polyclonal anti-laminin (a marker molecule for the basement membrane, 1:3000; Sigma-Aldrich, MO). The sections were washed in 0.1 M PBS and incubated with the secondary antibodies diluted in 0.1 M PBS containing 5% normal serum, and 0.1% Triton X-100 overnight at 4°C. Fluorescein-conjugated donkey anti-mouse IgG was used against mouse monoclonal primary antibodies and rhodamine-conjugated donkey anti-rabbit IgG was used against rabbit polyclonal antibodies (Chemicon, CA). To distinguish whether myoD-positive cells, triple immunostaining was performed co-localized with DAPI nuclei and pax7 to find out the ratio of myonuclei and satellite cells expressing MyoD. The sections were washed in 0.1 M PBS, and mounted in Vectashield mounting medium with DAPI (Vector Lab, CA) to visualize the nuclei. Immunofluorescence-stained sections were viewed on a conventional fluorescent microscope (BX60, Olympus, Tokyo, Japan) using the 20X objective. Images were captured on a digital device CCD camera system (DP-70, Olympus, Tokyo, Japan). We calculated the number of cells in each category (myoD-positive/pax7-positive, myoD-positive/pax7-negative, myoD-negative/pax7-positive). For each rat, three cross sections were counted and categorized by immunostaining.
All values are expressed as means ± standard deviations. Dunnett's multiple comparison test was performed to compare the torque and protein levels prior to, and on days 2, 5, and 7 after the LC. One-way analysis of variance (ANOVA) followed by Bonferroni test was used to test for differences in the body mass and muscle wet mass between the groups. Chi square test was used for analysis of the immunoreactive positive cells. Significance level was set at P < 0.05.
Body weight of rats and the wet weight of triceps surae muscles
Body weight and muscle wet weight
Pre (n = 6)
Day 2 (n = 6)
Day 5 (n = 6)
Day7 (n = 6)
Body mass (g)
262.9 ± 19.6
262.2 ± 11.0
270.6 ± 12.4
260.1 ± 17.3
Medial gastrocnemius (mg)
681.0 ± 23.5
687.4 ± 47.4
667.7 ± 73.9
645.4 ± 71.9
Lateral gastrocnemius (mg)
608.8 ± 46.8
640.4 ± 60.7
623.6 ± 27.2
636.8 ± 58.4
97.1 ± 15.4
98.0 ± 11.0
106.9 ± 5.3
103.4 ± 16.5
267.0 ± 21.9
269.3 ± 16.4
284.5 ± 13.1
279.0 ± 46.0
Isometric tetanic torque of the ankle joint after the lengthening contraction
Protein levels of muscles
Localization of pax7, myoD, and myogenin
We confirmed that the isometric tetanic torque significantly decreased until day 5 and recovered to almost the control level by day 7. On day 2 after LC, it decreased by 28.8% compared to the pre-treatment value. These results are almost consistent with Song et al., who employed similar equipment for LC-induced injury. Based on the time course change in muscle function, the destruction phase, the regeneration phase, and the remodeling phase are days 0–2, days 2–5, and days 5–7 after LC, respectively. In comparison with other injury models such as the myotoxic and contusion injury models, muscle strength decreased for 2–7 days after the injury, and recovered after > 14 days[26, 30]. We have also reported a >7 days recovery time when larger numbers of LCs were induced. Although the damage induced in this study was not as severe as compared to that in the aforementioned studies and actual muscle strain injuries, we can delineate the recovery process after muscle injury on the basis of changes in the isometric torque.
On day 2 after the LC-induced injury, the contents of myoD, myogenin, and pax7 were significantly increased. An increase in the expression of myoD and myogenin during skeletal muscle regeneration has been well documented in contusion and myotoxin treatment-induced muscle injury models[31–33]. Furthermore, we also examined pax7 expression to study the characteristics of myoD-positive nuclei (Figure3). Immunohistochemical staining revealed the presence of 3 cell populations on day 2 after the LC; myoD-positive/pax7-positive, myoD-positive/pax7-negative, and myoD-negative/pax7-positive cells, consistent with a previous report on a cultured myotube model by Zamitt et al.. Since myoD-positive/pax7-positive cells are regarded as activated satellite cells[16, 17], we believe that most of these cells would subsequently differentiate to regenerate muscle fibers during the destruction and early recovery phases.
On days 5 and 7 after the LC-induced injury, immunoblotting analysis revealed that contents of myogenin and myostatin were significantly higher than the pre-treatment values. Pax7 and myogenin expression in individual cells have been reported to occur in a mutually exclusive pattern[16, 34], as we confirmed in Figure2. Since Olgun et al. showed that myogenin is critical for pax7 downregulation in differentiating cells, we hypothesize that the myogenin-positive cells are further committed myoblasts. Since the content of myoD on day 5 was not significantly higher than the pre-treatment value in immunoblotting analysis, this suggests that committed myoblasts mainly contribute to form nascent muscle fibers in the late recovery phase.
Immunoblotting showed that the content of myostatin was higher on days 5 and 7, and this defined the late recovery and remodeling phases. Although the number of contractions was significantly different, we previously found that myostatin contents elevated higher on day 7 after 20 LCs. Myostatin is a member of the TGF-β superfamily and is known to maintain SC quiescence and to reduce myoblast recruitment and differentiation[21, 35]. Previous studies suggested that myostatin in regenerating muscle fibers played a role in modulating phagocytosis and inflammation. On the other hand, we observed that some myostatin positive cells also expressed pax7 (personal observation), suggesting that myostatin might also play a role in down-regulating myogenic regulatory factors to lead commitment cells to a quiescent, undifferentiated phenotype. Although authors have not explicitly commented, several reports showed that immunoreactive signals of myostatin antibody localized tissues other than myofibers[36, 37]. Since the loss of myostatin and/or the inhibition of smad-mediated signaling cause extensive muscle hypertrophy[23, 38], we would like to raise the possibility that myostatin negatively regulate myogenic cells to prevent hypercellularity in the late recovery and remodeling phases.
TGF-β and its superfamily are also known to induce connective tissue formation[18–20, 22]. We suggest that the higher expression of myostatin on days 5 and 7 after LC-induced injury results in the production of collagen and other extracellular matrices for the remodeling and repair of connective tissue. Yong et al. found that cardiotoxin-injured mouse muscle fibers expressed TGF-β1 within 5 days after the injury. After 5 days, TGF-β expressing myofibers were replaced by fibrotic mononuclear cells. Especially, fibrotic mononuclear cells might be a fibroblast cells and mainly produce collagen and other extracellular matrices. We hypothesize that myostatin mainly inhibit the proliferation of myogenic cells. The expression of TGF-β1 needs to be examined further, in order to understand the formation of connective tissue in the remodeling phase. We also consider that extracellular matrix proteins, such as tenascin-C and decorin, might regulate satellite cell proliferation and tissue regeneration[39–41].
Cares must be taken in the comparison between immunoblot and histochemical data because the thin sections were obtained from mid-belly and the specimens for SDS-PAGE were extracted from the whole muscle. Further, the isometric torque reflects the whole muscle characteristics. Since the skeletal muscle is heterogeneous tissue at the point of both metabolic and structural properties, comparisons of these parameters should be performed using samples collected from similar and appropriate parts of the muscle. For example, since our previous study confirmed that lengthening contraction damages were frequently seen near the musculotendinous junction, histochemical analysis for proximal and distal region may be performed to evaluate muscle damage and recovery. On the other hand, we found that immunochemical observation and pathological findings were almost temporally associated. Further, we also found that a change in the isometric torque showed temporal association with these molecular expressions. Taken together, we consider that the mechanical characteristics of the muscle show some association with the molecular events. These associations also suggest that the unfamiliar eccentric contractions in this study may exert microtraumas in the whole region of the gastrocnemius, as usually occurs during regular exercise.
We examined the relationship between the expression of myogenic proteins and functional changes in the skeletal muscle after a single bout of LC in vivo. Based on the isometric torque change, we roughly divided the regeneration process into 3 phases including destruction, recovery (days 0–5), and remodeling (days 5–7). On day 2 after the injury, significantly higher expressions of pax7 and myoD were observed. Our results also revealed myoD-positive/pax7-positive cells on day 2, suggesting that activated satellite cells play a role in the destruction and the early recovery phases. On day 5, myogenin level was significantly higher, suggesting that committed myoblasts mainly contribute in the late recovery phase. On days 5 and 7, a significantly high expression of myostatin was observed. We consider that myostatin inhibit to become hypercellularity in the remodeling phase. In conclusion, myogenic events are associated with torque recovery after LC-induced injury.
This study was supported by the Grant-in-Aid for Young Scientists (B; 23700784) and for Scientific Research (C; 23500788) from KAKENHI.
- Clarkson PM, Nosaka K, Braun B: Muscle function after exercise-induced muscle damage and rapid adaptation. Med Sci Sports Exerc. 1992, 24 (5): 512-520.PubMedGoogle Scholar
- Nosaka K, Clarkson PM: Muscle damage following repeated bouts of high force eccentric exercise. Med Sci Sports Exerc. 1995, 27 (9): 1263-1269.View ArticlePubMedGoogle Scholar
- Garrett WE: Muscle strain injuries. Am J Sports Med. 1996, 24 (6 Suppl): S2-S8.PubMedGoogle Scholar
- Zarins B, Ciullo JV: Acute muscle and tendon injuries in athletes. Clin Sports Med. 1983, 2 (1): 167-182.PubMedGoogle Scholar
- Best TM, McCabe RP, Corr D, Vanderby R: Evaluation of a new method to create a standardized muscle stretch injury. Med Sci Sports Exerc. 1998, 30 (2): 200-205. 10.1097/00005768-199802000-00005.View ArticlePubMedGoogle Scholar
- Nikolaou PK, Macdonald BL, Glisson RR, Seaber AV, Garrett WE: Biomechanical and histological evaluation of muscle after controlled strain injury. Am J Sports Med. 1987, 15 (1): 9-14. 10.1177/036354658701500102.View ArticlePubMedGoogle Scholar
- Tidball JG, Salem G, Zernicke R: Site and mechanical conditions for failure of skeletal muscle in experimental strain injuries. J Appl Physiol. 1993, 74 (3): 1280-1286.PubMedGoogle Scholar
- Song H, Nakazato K, Nakajima H: Effect of increased excursion of the ankle on the severity of acute eccentric contraction-induced strain injury in the gastrocnemius: an in vivo rat study. Am J Sports Med. 2004, 32 (5): 1263-1269. 10.1177/0363546503262199.View ArticlePubMedGoogle Scholar
- Jarvinen TA, Jarvinen TL, Kaariainen M, Kalimo H, Jarvinen M: Muscle injuries: biology and treatment. Am J Sports Med. 2005, 33 (5): 745-764. 10.1177/0363546505274714.View ArticlePubMedGoogle Scholar
- Hawke TJ, Garry DJ: Myogenic satellite cells: physiology to molecular biology. J Appl Physiol. 2001, 91 (2): 534-551.PubMedGoogle Scholar
- Ten Broek RW, Grefte S, Von den Hoff JW: Regulatory factors and cell populations involved in skeletal muscle regeneration. J Cell Physiol. 2010, 224 (1): 7-16.PubMedGoogle Scholar
- Seale P, Ishibashi J, Scime A, Rudnicki MA: Pax7 is necessary and sufficient for the myogenic specification of CD45+:Sca1+ stem cells from injured muscle. PLoS Biol. 2004, 2 (5): E130-10.1371/journal.pbio.0020130.View ArticlePubMedPubMed CentralGoogle Scholar
- Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, Rudnicki MA: Pax7 is required for the specification of myogenic satellite cells. Cell. 2000, 102 (6): 777-786. 10.1016/S0092-8674(00)00066-0.View ArticlePubMedGoogle Scholar
- Cooper RN, Tajbakhsh S, Mouly V, Cossu G, Buckingham M, Butler-Browne GS: In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. J Cell Sci. 1999, 112 (Pt 17): 2895-2901.PubMedGoogle Scholar
- Olguin HC, Yang Z, Tapscott SJ, Olwin BB: Reciprocal inhibition between Pax7 and muscle regulatory factors modulates myogenic cell fate determination. J Cell Biol. 2007, 177 (5): 769-779. 10.1083/jcb.200608122.View ArticlePubMedPubMed CentralGoogle Scholar
- Zammit PS, Golding JP, Nagata Y, Hudon V, Partridge TA, Beauchamp JR: Muscle satellite cells adopt divergent fates: a mechanism for self-renewal?. J Cell Biol. 2004, 166 (3): 347-357. 10.1083/jcb.200312007.View ArticlePubMedPubMed CentralGoogle Scholar
- Zammit PS, Partridge TA, Yablonka-Reuveni Z: The skeletal muscle satellite cell: the stem cell that came in from the cold. J Histochem Cytochem. 2006, 54 (11): 1177-1191. 10.1369/jhc.6R6995.2006.View ArticlePubMedGoogle Scholar
- Kovacs EJ, DiPietro LA: Fibrogenic cytokines and connective tissue production. FASEB J. 1994, 8 (11): 854-861.PubMedGoogle Scholar
- Acharyya S, Ladner KJ, Nelsen LL, Damrauer J, Reiser PJ, Swoap S, Guttridge DC: Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest. 2004, 114 (3): 370-378.View ArticlePubMedPubMed CentralGoogle Scholar
- Hirose T, Nakazato K, Song H, Ishii N: TGF-beta1 and TNF-alpha are involved in the transcription of type I collagen alpha2 gene in soleus muscle atrophied by mechanical unloading. J Appl Physiol. 2008, 104 (1): 170-177.View ArticlePubMedGoogle Scholar
- Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J, Kambadur R: Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem. 2000, 275 (51): 40235-40243. 10.1074/jbc.M004356200.View ArticlePubMedGoogle Scholar
- Mendias CL, Bakhurin KI, Faulkner JA: Tendons of myostatin-deficient mice are small, brittle, and hypocellular. Proc Natl Acad Sci U S A. 2008, 105 (1): 388-393. 10.1073/pnas.0707069105.View ArticlePubMedGoogle Scholar
- Cadena SM, Tomkinson KN, Monnell TE, Spaits MS, Kumar R, Underwood KW, Pearsall RS, Lachey JL: Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type. J Appl Physiol. 2010, 109 (3): 635-642. 10.1152/japplphysiol.00866.2009.View ArticlePubMedPubMed CentralGoogle Scholar
- Beitzel F, Gregorevic P, Ryall JG, Plant DR, Sillence MN, Lynch GS: Beta2-adrenoceptor agonist fenoterol enhances functional repair of regenerating rat skeletal muscle after injury. J Appl Physiol. 2004, 96 (4): 1385-1392. 10.1152/japplphysiol.01081.2003.View ArticlePubMedGoogle Scholar
- Crisco JJ, Jokl P, Heinen GT, Connell MD, Panjabi MM: A muscle contusion injury model. Biomechanics, physiology, and histology. Am J Sports Med. 1994, 22 (5): 702-710. 10.1177/036354659402200521.View ArticlePubMedGoogle Scholar
- Iwata A, Fuchioka S, Hiraoka K, Masuhara M, Kami K: Characteristics of locomotion, muscle strength, and muscle tissue in regenerating rat skeletal muscles. Muscle Nerve. 2010, 41 (5): 694-701. 10.1002/mus.21567.View ArticlePubMedGoogle Scholar
- Nakazato K, Ochi E, Waga T: Dietary apple polyphenols have preventive effects against lengthening contraction-induced muscle injuries. Mol Nutr Food Res. 2010, 54 (3): 364-372. 10.1002/mnfr.200900145.View ArticlePubMedGoogle Scholar
- Baumann AP, Ibebunjo C, Grasser WA, Paralkar VM: Myostatin expression in age and denervation-induced skeletal muscle atrophy. J Musculoskelet Neuronal Interact. 2003, 3 (1): 8-16.PubMedGoogle Scholar
- Taylor WE, Bhasin S, Artaza J, Byhower F, Azam M, Willard DH, Kull FC, Gonzalez-Cadavid N: Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am J Physiol Endocrinol Metab. 2001, 280 (2): E221-E228.PubMedGoogle Scholar
- Ryall JG, Schertzer JD, Alabakis TM, Gehrig SM, Plant DR, Lynch GS: Intramuscular beta2-agonist administration enhances early regeneration and functional repair in rat skeletal muscle after myotoxic injury. J Appl Physiol. 2008, 105 (1): 165-172. 10.1152/japplphysiol.00317.2007.View ArticlePubMedGoogle Scholar
- Garry DJ, Yang Q, Bassel-Duby R, Williams RS: Persistent expression of MNF identifies myogenic stem cells in postnatal muscles. Dev Biol. 1997, 188 (2): 280-294. 10.1006/dbio.1997.8657.View ArticlePubMedGoogle Scholar
- Rantanen J, Hurme T, Lukka R, Heino J, Kalimo H: Satellite cell proliferation and the expression of myogenin and desmin in regenerating skeletal muscle: evidence for two different populations of satellite cells. Lab Invest. 1995, 72 (3): 341-347.PubMedGoogle Scholar
- Kami K, Senba E: In vivo activation of STAT3 signaling in satellite cells and myofibers in regenerating rat skeletal muscles. J Histochem Cytochem. 2002, 50 (12): 1579-1589. 10.1177/002215540205001202.View ArticlePubMedGoogle Scholar
- Olguin HC, Olwin BB: Pax-7 up-regulation inhibits myogenesis and cell cycle progression in satellite cells: a potential mechanism for self-renewal. Dev Biol. 2004, 275 (2): 375-388. 10.1016/j.ydbio.2004.08.015.View ArticlePubMedPubMed CentralGoogle Scholar
- McCroskery S, Thomas M, Maxwell L, Sharma M, Kambadur R: Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol. 2003, 162 (6): 1135-1147. 10.1083/jcb.200207056.View ArticlePubMedPubMed CentralGoogle Scholar
- Kirk S, Oldham J, Kambadur R, Sharma M, Dobbie P, Bass J: Myostatin regulation during skeletal muscle regeneration. J Cell Physiol. 2000, 184 (3): 356-363. 10.1002/1097-4652(200009)184:3<356::AID-JCP10>3.0.CO;2-R.View ArticlePubMedGoogle Scholar
- Nishimura T, Oyama K, Kishioka Y, Wakamatsu J, Hattori A: Spatiotemporal expression of decorin and myostatin during rat skeletal muscle development. Biochem Biophys Res Commun. 2007, 361 (4): 896-902. 10.1016/j.bbrc.2007.07.104.View ArticlePubMedGoogle Scholar
- McPherron AC, Lawler AM, Lee SJ: Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997, 387 (6628): 83-90. 10.1038/387083a0.View ArticlePubMedGoogle Scholar
- Fluck M, Chiquet M, Schmutz S, Mayet-Sornay MH, Desplanches D: Reloading of atrophied rat soleus muscle induces tenascin-C expression around damaged muscle fibers. Am J Physiol Regul Integr Comp Physiol. 2003, 284 (3): R792-R801.View ArticlePubMedGoogle Scholar
- Fluck M, Mund SI, Schittny JC, Klossner S, Durieux AC, Giraud MN: Mechano-regulated tenascin-C orchestrates muscle repair. Proc Natl Acad Sci U S A. 2008, 105 (36): 13662-13667. 10.1073/pnas.0805365105.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhu J, Li Y, Shen W, Qiao C, Ambrosio F, Lavasani M, Nozaki M, Branca MF, Huard J: Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. J Biol Chem. 2007, 282 (35): 25852-25863. 10.1074/jbc.M704146200.View ArticlePubMedGoogle Scholar
- De Ruiter CJ, De Haan A, Sargeant AJ: Physiological characteristics of two extreme muscle compartments in gastrocnemius medialis of the anaesthetized rat. Acta Physiol Scand. 1995, 153 (4): 313-324. 10.1111/j.1748-1716.1995.tb09869.x.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2474/13/211/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.